GlassScriptPhysician profile
Farhan Hooda
NPI 1417382912
$5,733.83
in general payments reported to CMS, 2019-2025
37 companies · $875 in 2025
The $875 reported for 2025 was more than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,273 · 2020: $455 · 2021: $581 · 2022: $708 · 2023: $1,009 · 2024: $834 · 2025: $875.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,626 · Education: $91.95.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,625.98 |
| Education | $91.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $672.67 | 2019-2025 | Diamondback Coronary, Cardiomems, Navitor |
| Pfizer INC. | $539.94 | 2019-2025 | |
| Amgen INC. | $485.04 | 2020-2024 | Repatha |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $408.48 | 2019-2024 | Lifevest |
| Novartis Pharmaceuticals Corporation | $311.19 | 2021-2025 | |
| Boston Scientific Corporation | $293.00 | 2019-2023 | Bodyguardian |
| E.R. Squibb & Sons, L.L.C. | $276.79 | 2022-2025 | Camzyos, Eliquis |
| Janssen Pharmaceuticals, INC | $268.26 | 2019-2023 | Xarelto |
| Esperion Therapeutics, INC. | $241.17 | 2020-2025 | Nexletol, Nexlizet |
| Medtronic, INC. | $207.95 | 2022-2025 | Cobalt Dr Mri Surescan, Micra |
| Boehringer Ingelheim Pharmaceuticals, INC. | $206.56 | 2020-2025 | Jardiance |
| Alnylam Pharmaceuticals INC. | $181.21 | 2024-2025 | Onpattro |
| Merck Sharp & Dohme LLC | $165.61 | 2021-2024 | Verquvo |
| Amarin Pharma, INC. | $161.80 | 2020-2022 | |
| Philips North America LLC | $130.74 | 2022-2025 | Extended Holter, Mcot |
Show all 37 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $122.44 | 2022-2025 | Wegovy |
| Medtronic Vascular, INC. | $119.70 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $117.31 | 2019-2022 | |
| Actelion Pharmaceuticals US, INC. | $113.82 | 2024-2025 | Opsumit, Uptravi |
| Bayer Healthcare Pharmaceuticals INC. | $77.45 | 2023-2025 | |
| Tersera Therapeutics LLC | $77.30 | 2019 | |
| Medicure Pharma INC. | $74.05 | 2019 | |
| Sanofi-Aventis U.S. LLC | $69.79 | 2020-2022 | |
| Regeneron Healthcare Solutions, INC. | $63.34 | 2023-2025 | Evkeeza |
| Lexicon Pharmaceuticals, INC. | $46.38 | 2023-2024 | Inpefa |
| Abiomed | $39.42 | 2024 | Impella |
| Cvrx, INC. | $35.13 | 2025 | Barostim Neo System |
| Chiesi USA, INC. | $34.97 | 2020-2023 | Kengreal |
| Heartflow, INC. | $28.54 | 2019 | |
| Kiniksa Pharmaceuticals, LTD. | $27.25 | 2022-2023 | Arcalyst |
| Cardiovascular Systems INC. | $24.56 | 2019 | |
| Baxter Healthcare | $23.64 | 2024 | Hillrom - Cardiac Ambulatory Monitor |
| Angiodynamics, INC. | $19.23 | 2022 | |
| Vital Connect, INC | $18.31 | 2023 | Vitalpatch Rtm |
| Terumo Medical Corporation | $17.10 | 2019 | |
| Scpharmaceuticals INC. | $16.91 | 2025 | |
| Kiniksa Pharmaceuticals International, Plc | $16.78 | 2024 | Arcalyst |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Farhan Hooda listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.